The role of four oestrogen-responsive genes, pLIV1, pS2, pSYD3 and pSYD8, in predicting responsiveness to endocrine therapy in primary breast cancer
- 1 January 1993
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (10) , 1462-1468
- https://doi.org/10.1016/0959-8049(93)90021-7
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivityEuropean Journal Of Cancer, 1993
- Heterogeneity of oestrogen receptor expression in normal and malignant breast tissueEuropean Journal Of Cancer, 1992
- Influence of the antioestrogen tamoxifen on normal breast tissueBritish Journal of Cancer, 1991
- Hormone sensitivity in breast cancer: Influence of heterogeneity of oestrogen receptor expression and cell proliferationEuropean Journal of Cancer and Clinical Oncology, 1991
- Ki67 immunostaining in primary breast cancer: pathological and clinical associationsBritish Journal of Cancer, 1989
- Effects of oestrogen on the expression of a 4.4 kb mRNA in the ZR-75-1 human breast cancer cell lineMolecular and Cellular Endocrinology, 1988
- Steroid-hormone receptors in breast cancerCancer, 1984
- Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell lineNucleic Acids Research, 1982
- QUANTITATIVE OESTRADIOL RECEPTOR VALUES IN PRIMARY BREAST CANCER AND RESPONSE OF METASTASES TO ENDOCRINE THERAPYThe Lancet, 1981
- Predicting Response to Endocrine Therapy in Human Breast Cancer: A HypothesisScience, 1975